300110 华仁药业
已收盘 11-02 15:00:00
资讯
新帖
简况
华仁药业(300110)10月9日股东户数5.58万户,较上期增加6.38%
证券之星 · 10-28
华仁药业(300110)10月9日股东户数5.58万户,较上期增加6.38%
图解华仁药业三季报:第三季度单季净利润同比下降109.44%
证券之星 · 10-28
图解华仁药业三季报:第三季度单季净利润同比下降109.44%
股市必读:华仁药业新发布《关于全资子公司复合磷酸氢钾注射液取得药品注册证书的公告》
证券之星 · 10-26
股市必读:华仁药业新发布《关于全资子公司复合磷酸氢钾注射液取得药品注册证书的公告》
华仁药业最新公告:全资子公司复合磷酸氢钾注射液获药品注册证书
证券之星 · 10-23
华仁药业最新公告:全资子公司复合磷酸氢钾注射液获药品注册证书
华仁药业:截至2026年10月9日,公司股东户数约5.58万户
证券之星 · 10-16
华仁药业:截至2026年10月9日,公司股东户数约5.58万户
华仁药业3亿诉讼追债:14亿坏账背后的资产质量隐忧
新浪证券 · 10-16
华仁药业3亿诉讼追债:14亿坏账背后的资产质量隐忧
华仁药业(300110)披露子公司涉及重大诉讼公告,10月9日股价上涨5.08%
证券之星 · 10-09
华仁药业(300110)披露子公司涉及重大诉讼公告,10月9日股价上涨5.08%
华仁药业:公司经营情况一切正常
证券之星 · 09-30
华仁药业:公司经营情况一切正常
华仁药业:已严格依照治理规则及监管要求开展内部责任核查与处置相关工作
证券之星 · 09-30
华仁药业:已严格依照治理规则及监管要求开展内部责任核查与处置相关工作
华仁药业(300110)披露股票交易异常波动公告,9月23日股价下跌7.59%
证券之星 · 09-23
华仁药业(300110)披露股票交易异常波动公告,9月23日股价下跌7.59%
异动快报:华仁药业(300110)9月22日10点50分触及涨停板
证券之星 · 09-22
异动快报:华仁药业(300110)9月22日10点50分触及涨停板
9月21日华仁药业(300110)龙虎榜数据
证券之星 · 09-21
9月21日华仁药业(300110)龙虎榜数据
异动快报:华仁药业(300110)9月21日10点38分触及涨停板
证券之星 · 09-21
异动快报:华仁药业(300110)9月21日10点38分触及涨停板
华仁药业:截至2026年8月31日,公司股东总户数约为4.21万户
证券之星 · 09-08
华仁药业:截至2026年8月31日,公司股东总户数约为4.21万户
华仁药业(300110)8月20日股东户数3.99万户,较上期增加1.01%
证券之星 · 08-27
华仁药业(300110)8月20日股东户数3.99万户,较上期增加1.01%
股市必读:华仁药业新发布《第八届董事会第十六次会议决议公告》
证券之星 · 08-27
股市必读:华仁药业新发布《第八届董事会第十六次会议决议公告》
华仁药业:截至2026年8月20日,公司股东总户数约为3.99万户
证券之星 · 08-25
华仁药业:截至2026年8月20日,公司股东总户数约为3.99万户
股市必读:华仁药业(300110)8月13日董秘有最新回复
证券之星 · 08-14
股市必读:华仁药业(300110)8月13日董秘有最新回复
华仁药业:截至2026年7月31日,公司股东总户数约为3.94万户
证券之星 · 08-13
华仁药业:截至2026年7月31日,公司股东总户数约为3.94万户
股市必读:华仁药业(300110)8月5日董秘有最新回复
证券之星 · 08-06
股市必读:华仁药业(300110)8月5日董秘有最新回复
加载更多
公司概况
公司名称:
华仁药业股份有限公司
所属行业:
医药制造业
上市日期:
2010-08-25
主营业务:
华仁药业股份有限公司的主营业务是原料药、制剂、医疗器械、医用包材、大健康产品的研发、生产、销售。公司的主要产品是基础输液、腹膜透析液、小容量注射剂、治疗性输液、片剂、胶囊剂、散剂、颗粒剂、医疗器械、配套医用包材、大健康产品、原料药。公司先后获得“全国AAA级信用企业”、“国家知识产权优势/示范企业”、“中国化学制药行业工业企业综合实力百强”、“中国医药工业百强”、“山东省质量管理奖”、“山东省高端品牌培育企业”、“‘品质鲁药’建设示范企业”等系列荣誉。
发行价格:
13.99
{"stockData":{"symbol":"300110","market":"SZ","secType":"STK","nameCN":"华仁药业","latestPrice":2.62,"timestamp":1793603034000,"preClose":2.54,"halted":0,"volume":43130185,"delay":0,"changeRate":0.0315,"floatShares":1181000000,"shares":1182000000,"eps":-0.415,"marketStatus":"已收盘","change":0.08,"latestTime":"11-02 15:00:00","open":2.6,"high":2.63,"low":2.51,"amount":111000000,"amplitude":0.0472,"askPrice":2.62,"askSize":7071,"bidPrice":2.61,"bidSize":2558,"shortable":0,"etf":0,"ttmEps":-0.415,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793669400000},"marketStatusCode":5,"adr":0,"adjPreClose":2.54,"symbolType":"stock","openAndCloseTimeList":[[1793583000000,1793590200000],[1793595600000,1793602800000]],"highLimit":2.79,"lowLimit":2.29,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1182212982,"isCdr":false,"pbRate":3.47,"roa":"--","roe":"3.16%","epsLYR":-0.3916,"committee":-0.389021,"marketValue":3097000000,"turnoverRate":0.0365,"status":0,"floatMarketCap":3095000000},"requestUrl":"/m/hq/s/300110","defaultTab":"news","newsList":[{"id":"2678646681","title":"华仁药业(300110)10月9日股东户数5.58万户,较上期增加6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678646681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678646681?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:46","pubTimestamp":1793184403,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华仁药业披露,截至2026年10月9日公司股东户数为5.58万户,较9月30日增加3345.0户,增幅为6.38%。在化学制药行业个股中,华仁药业股东户数高于行业平均水平,截至10月9日,化学制药行业平均股东户数为3.9万户。从股价来看,2026年9月30日至2026年10月9日,华仁药业区间涨幅为4.42%,在此期间股东户数增加3345.0户,增幅为6.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800041011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678071611","title":"图解华仁药业三季报:第三季度单季净利润同比下降109.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678071611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678071611?lang=zh_cn&edition=full","pubTime":"2026-10-28 02:33","pubTimestamp":1793125993,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业2026年三季报显示,前三季度公司主营收入8.74亿元,同比下降10.48%;归母净利润2691.47万元,同比下降50.69%;扣非净利润2256.56万元,同比下降50.65%;其中2026年第三季度,公司单季度主营收入2.69亿元,同比下降23.68%;单季度归母净利润-162.77万元,同比下降109.44%;单季度扣非净利润-288.48万元,同比下降115.99%;负债率65.48%,投资收益336.9万元,财务费用2688.37万元,毛利率31.61%。财报数据概要请见下图:本文数据来源于华仁药业2026年三季报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800002930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678139407","title":"股市必读:华仁药业新发布《关于全资子公司复合磷酸氢钾注射液取得药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678139407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678139407?lang=zh_cn&edition=full","pubTime":"2026-10-26 05:14","pubTimestamp":1792962852,"startTime":"0","endTime":"0","summary":"公司公告汇总关于全资子公司复合磷酸氢钾注射液取得药品注册证书的公告华仁药业全资子公司华仁药业(日照)有限公司收到国家药品监督管理局核准签发的复合磷酸氢钾注射液《药品注册证书》,注册分类为化学药品3类,视同通过一致性评价。生产企业为山东华鲁制药有限公司,药品批准文号有效期至2031年10月19日。公司将严格遵守相关规定及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600001301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677940641","title":"华仁药业最新公告:全资子公司复合磷酸氢钾注射液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2677940641","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677940641?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:38","pubTimestamp":1792748322,"startTime":"0","endTime":"0","summary":"华仁药业(300110.SZ)公告称,公司全资子公司华仁药业(日照)有限公司收到国家药监局核准签发的复合磷酸氢钾注射液《药品注册证书》,该药品为化学药品3类,视同通过一致性评价。该药品用于纠正成人和儿童患者的低磷血症及肠外营养。2025年国内医疗市场该药品销售总额为3.54亿元。此次获批将进一步丰富公司产品线,优化产品结构。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300032042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675190592","title":"华仁药业:截至2026年10月9日,公司股东户数约5.58万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2675190592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675190592?lang=zh_cn&edition=full","pubTime":"2026-10-16 20:48","pubTimestamp":1792154908,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)10月16日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年10月9日A股股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年10月9日,公司股东户数约5.58万户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600037832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675561760","title":"华仁药业3亿诉讼追债:14亿坏账背后的资产质量隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2675561760","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675561760?lang=zh_cn&edition=full","pubTime":"2026-10-16 15:39","pubTimestamp":1792136340,"startTime":"0","endTime":"0","summary":"随着全资子公司青岛华仁正式起诉中民信投与国药药材,总额超14亿元的历史遗留应收款正式进入司法挽损阶段,也暴露了公司贸易业务潜藏的资产质量风险。01诉讼追债落地,14亿历史坏账启动司法挽损根据公告,青岛华仁已向青岛市中级人民法院提起诉讼,向中民信投、国药药材追偿合计3.21亿元债权,目前案件已获受理。对于华仁药业而言,历史坏账已经对利润造成冲击,后续追偿进展不及预期还可能带来额外损失。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-10-16/doc-inivmazf7019516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","300110","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674857018","title":"华仁药业(300110)披露子公司涉及重大诉讼公告,10月9日股价上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674857018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674857018?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:08","pubTimestamp":1791554914,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘,华仁药业报收于3.31元,较前一交易日上涨5.08%,最新总市值为39.13亿元。该股当日开盘3.22元,最高3.32元,最低3.11元,成交额达5.82亿元,换手率为15.24%。华仁药业于近日披露《关于子公司涉及重大诉讼的公告》。公告显示,公司全资子公司青岛华仁医药有限公司作为原告,就中民信投集团有限公司未按约清偿3.08亿元债务、国药药材股份有限公司未履行连带责任一事提起诉讼,涉案金额321,138,766.67元,法院已受理,尚未开庭。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900038006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671202599","title":"华仁药业:公司经营情况一切正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2671202599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671202599?lang=zh_cn&edition=full","pubTime":"2026-09-30 20:51","pubTimestamp":1790772670,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业09月29日在投资者关系平台上答复投资者关心的问题。公司近期已完成董事会及经营管理班子换届,新一届管理团队将持续深耕主业,扎实推进各项改革举措。公司将严格遵守相关规定,及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000036032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671920256","title":"华仁药业:已严格依照治理规则及监管要求开展内部责任核查与处置相关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2671920256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671920256?lang=zh_cn&edition=full","pubTime":"2026-09-30 20:51","pubTimestamp":1790772667,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)09月29日在投资者关系平台上答复投资者关心的问题。投资者提问:管理期间犯下这么大的错误。十几亿无法收回。为什么没有内部追责?华仁药业回复:尊敬的投资者您好,公司已严格依照治理规则及监管要求开展内部责任核查与处置相关工作,压实管理责任,保障公司权益。公司将严格遵守相关规定,及时履行信息披露义务。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000036029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669045341","title":"华仁药业(300110)披露股票交易异常波动公告,9月23日股价下跌7.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669045341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669045341?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:29","pubTimestamp":1790155744,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘,华仁药业报收于3.65元,较前一交易日下跌7.59%,最新总市值为43.15亿元。该股当日开盘3.89元,最高3.98元,最低3.54元,成交额达11.44亿元,换手率为26.24%。公司于近日披露《关于股票交易异常波动的公告》。公告显示,华仁药业股份有限公司股票于2026年9月21日、22日连续两个交易日收盘价格涨幅偏离值累计超过30%,属于股票交易异常波动。公司2026年上半年实现营业收入6.05亿元,同比下降3.02%;净利润2854.24万元,同比下降23.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300029844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669190536","title":"异动快报:华仁药业(300110)9月22日10点50分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2669190536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669190536?lang=zh_cn&edition=full","pubTime":"2026-09-22 10:55","pubTimestamp":1790045724,"startTime":"0","endTime":"0","summary":"证券之星9月22日盘中消息,10点50分华仁药业(300110)触及涨停板。其所属行业化学制药目前上涨。领涨股为华仁药业。该股为猴痘概念,医疗器械,流感概念热股,当日猴痘概念概念上涨2.78%,医疗器械概念上涨1.94%,流感概念上涨1.58%。9月21日的资金流向数据方面,主力资金净流入1.72亿元,占总成交额28.64%,游资资金净流出9925.91万元,占总成交额16.5%,散户资金净流出7301.58万元,占总成交额12.14%。近5日资金流向一览见下表:华仁药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200012764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669154045","title":"9月21日华仁药业(300110)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2669154045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669154045?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:46","pubTimestamp":1789983963,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年9月21日公布的交易公开信息显示,华仁药业因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年9月21日收盘,华仁药业报收于3.29元,上涨20.07%,涨停,换手率15.89%,成交量187.71万手,成交额6.02亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100022934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669823131","title":"异动快报:华仁药业(300110)9月21日10点38分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2669823131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669823131?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:40","pubTimestamp":1789958459,"startTime":"0","endTime":"0","summary":"证券之星9月21日盘中消息,10点38分华仁药业(300110)触及涨停板。其所属行业化学制药目前上涨。领涨股为亚虹医药科技。该股为猴痘概念,流感,医药概念热股,当日猴痘概念概念上涨4.45%,流感概念上涨3.82%,医药概念上涨3.68%。9月18日的资金流向数据方面,主力资金净流入339.59万元,占总成交额5.03%,游资资金净流入545.93万元,占总成交额8.09%,散户资金净流出885.52万元,占总成交额13.12%。近5日资金流向一览见下表:华仁药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100006823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373650","title":"华仁药业:截至2026年8月31日,公司股东总户数约为4.21万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373650","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665373650?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:54","pubTimestamp":1788872077,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)09月08日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月31日A股股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年8月31日,公司股东总户数约为4.21万户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800034610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662870345","title":"华仁药业(300110)8月20日股东户数3.99万户,较上期增加1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662870345","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662870345?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:12","pubTimestamp":1787825549,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华仁药业披露,截至2026年8月20日公司股东户数为3.99万户,较8月10日增加400.0户,增幅为1.01%。在化学制药行业个股中,华仁药业股东户数高于行业平均水平,截至8月20日,化学制药行业平均股东户数为3.67万户。从股价来看,2026年8月10日至2026年8月20日,华仁药业区间涨幅为5.34%,在此期间股东户数增加400.0户,增幅为1.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662723052","title":"股市必读:华仁药业新发布《第八届董事会第十六次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662723052","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662723052?lang=zh_cn&edition=full","pubTime":"2026-08-27 07:58","pubTimestamp":1787788696,"startTime":"0","endTime":"0","summary":"关于变更董事会专门委员会名称并修订其工作制度、修订《公司章程》及公司部分制度的公告华仁药业第八届董事会第十六次会议审议通过变更董事会专门委员会名称并修订其工作制度、修订《公司章程》及公司部分制度的议案。关于董事会换届选举的公告华仁药业第八届董事会任期届满,进行换届选举。独立董事候选人需经深交所审核无异议后方可提交股东大会表决。现任董事会成员在新一届董事会就任前继续履职。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700014517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732281","title":"华仁药业:截至2026年8月20日,公司股东总户数约为3.99万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732281","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662732281?lang=zh_cn&edition=full","pubTime":"2026-08-25 20:48","pubTimestamp":1787662105,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)08月24日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月20日A股股东人数是多少?谢谢华仁药业回复:您好!截至2026年8月20日,公司股东总户数约为3.99万户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500047165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169932","title":"股市必读:华仁药业(300110)8月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659169932?lang=zh_cn&edition=full","pubTime":"2026-08-14 00:55","pubTimestamp":1786640110,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘,华仁药业报收于3.01元,上涨3.44%,换手率6.04%,成交量71.38万手,成交额2.14亿元。董秘最新回复投资者: 为什么多少年都走的这么纠结,无人问津,欠款还能收回吗?内控方面,公司严格按照国资监管相关规章制度、上市公司治理规则开展经营管理工作,各项决策、内控及经营管理流程同步遵循国资管理规范与上市公司监管要求。当日关注点交易信息汇总:8月13日主力资金净流入1925.05万元,占总成交额9.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400000694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152471","title":"华仁药业:截至2026年7月31日,公司股东总户数约为3.94万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659152471?lang=zh_cn&edition=full","pubTime":"2026-08-13 20:48","pubTimestamp":1786625299,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止到7月31日公司股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年7月31日,公司股东总户数约为3.94万户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300037319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657452106","title":"股市必读:华仁药业(300110)8月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657452106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657452106?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:53","pubTimestamp":1785952392,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘,华仁药业报收于2.7元,下跌1.46%,换手率1.75%,成交量20.7万手,成交额5607.71万元。董秘最新回复投资者: 尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。谢谢董秘: 您好,截至2026年7月31日,公司股东总户数约为3.94万户。交易信息汇总资金流向8月5日主力资金净流出306.93万元,占总成交额5.47%;游资资金净流入197.18万元,占总成交额3.52%;散户资金净流入109.75万元,占总成交额1.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793613283456,"stockEarnings":[{"period":"1week","weight":-0.0764},{"period":"1month","weight":-0.1987},{"period":"3month","weight":-0.0522},{"period":"6month","weight":-0.1937},{"period":"1year","weight":-0.2349},{"period":"ytd","weight":-0.1937}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华仁药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"55800人(较上一季度增加6.38%)","perCapita":"21172股","listingDate":"2010-08-25","address":"山东省青岛市崂山区高科技工业园株洲路187号","registeredCapital":"118221万元","survey":" 华仁药业股份有限公司的主营业务是原料药、制剂、医疗器械、医用包材、大健康产品的研发、生产、销售。公司的主要产品是基础输液、腹膜透析液、小容量注射剂、治疗性输液、片剂、胶囊剂、散剂、颗粒剂、医疗器械、配套医用包材、大健康产品、原料药。公司先后获得“全国AAA级信用企业”、“国家知识产权优势/示范企业”、“中国化学制药行业工业企业综合实力百强”、“中国医药工业百强”、“山东省质量管理奖”、“山东省高端品牌培育企业”、“‘品质鲁药’建设示范企业”等系列荣誉。","listedPrice":13.99},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华仁药业,300110,华仁药业股票,华仁药业股票老虎,华仁药业股票老虎国际,华仁药业行情,华仁药业股票行情,华仁药业股价,华仁药业股市,华仁药业股票价格,华仁药业股票交易,华仁药业股票购买,华仁药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}